Conditioning Treatment With Umbilical Cord Blood Transplant for Hematologic Malignancies
Status:
Terminated
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
This is a phase II study to assess the day 180 event free and overall survival after
administration of a specified combination of fludarabine, busulfan, Total Body Irradiation
(TBI), and thymoglobulin reduced intensity conditioning and 2 unit UCB stem cell transplant
in a single institution setting in patients with hematologic malignancies for whom allogeneic
transplantation is indicated.